• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

What Really Killed COVID-19 Patients?

May 6, 2023 by Deborah Bloomfield

A new study that used machine learning algorithms on medical data from intensive care patients has found evidence that the main driver in COVID-19 deaths is not cytokine storms, as previously thought.

The team from Northwestern University looked at the medical records of 585 patients in the intensive care unit (ICU) at Northwestern Memorial Hospital who had severe pneumonia, 190 of whom had COVID-19. They applied machine learning to the data, to look at possible factors associated with mortality.

Advertisement

“The term ‘cytokine storm’ means an overwhelming inflammation that drives organ failure in your lungs, your kidneys, your brain and other organs,” senior author of the paper Dr. Benjamin Singer said in a statement. “If that were true, if cytokine storm were underlying the long length of stay we see in patients with COVID-19, we would expect to see frequent transitions to states that are characterized by multi-organ failure. That’s not what we saw.”

One potential factor they had been looking for was secondary pneumonia.

“Recent data suggest that secondary pneumonia is present in up to 40% and pneumonia or diffuse alveolar damage is present in over 90% of autopsy specimens obtained from patients with acute SARS-CoV-2 infection,” the team wrote in their study.

Sure enough, the team found nearly half of COVID-19 patients who required mechanical ventilation acquired ventilator-associated pneumonia (VAP).

Advertisement

“Those who were cured of their secondary pneumonia were likely to live, while those whose pneumonia did not resolve were more likely to die,” Singer added. “Our data suggested that the mortality related to the virus itself is relatively low, but other things that happen during the ICU stay, like secondary bacterial pneumonia, offset that.”

“Our study highlights the importance of preventing, looking for and aggressively treating secondary bacterial pneumonia in critically ill patients with severe pneumonia, including those with COVID-19,” he said.

While intriguing, the team writes in their discussion that the study has a number of important limitations, including that “as ours is an observational study, we cannot exclude unmeasured confounders that link unresolving VAP to poor outcomes”, such as hospital practices around ventilators, and their antibiotic management strategies.

The team next wants to apply the machine learning tool, which they’ve called CarpeDiem, to larger datasets in an attempt to improve clinical care. As well as this, they plan to apply machine learning to molecular data from the study samples, to try to work out why some patients survive pneumonia and others don’t.

Advertisement

The study was published in the Journal of Clinical Investigation.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Kroger expects smaller decline in same-store sales on grocery demand
  2. Libya presidency council head plans to hold October conference
  3. Tikehau Capital aims for around 5 billion euros of assets dedicated to tackling climate change
  4. Think Your Country Is Hot On Abortion Rights? Think Again

Source Link: What Really Killed COVID-19 Patients?

Filed Under: News

Primary Sidebar

  • Why Is It So Difficult To Find New Moons In The Solar System?
  • New “Oxygen-Breathing” Crystal Could Recharge Fuel Cells And More
  • Some Gut Bacteria Cause Insomnia While Others Protect Against It, 400,000-Person Study Argues
  • Neanderthals And Homo Sapiens Got It On 100,000 Years Earlier Than We Thought
  • “Womb Of The Universe”: Native American Tribal Elders Help Archaeologists Decipher Ancient Rock Art In Missouri Cave
  • 16,000-Year-Old Paintings Suggest Prehistoric Humans Risked Their Lives To Enter “Shaman Training Cave”
  • Final Gasps Of A Dying Star Seen Through A Record-Breaking 130 Years Of Data
  • COVID-19 “Vaccine Alternative” Injection Could Be On Fast-Track To Approval From FDA
  • New Jersey Officials Investigate Possible First Locally Acquired Malaria Case Since 1991
  • First-of-Its-Kind Bright Orange Nurse Shark Recorded Off Costa Rica Makes History
  • JWST Spots Tiny New Moon Just Outside Uranus’s Rings, Bringing Total to 29
  • New Fossil Trackways Reveal Fish Left The Ocean 10 Million Years Earlier Than Thought
  • Thousands Of Bumblebee Catfish Seen Literally Climbing The Walls For The First Time Ever
  • Massive Hydrogen-Rich Hydrothermal System Discovered In Pacific 100 Times Larger Than Atlantic’s “Lost City”
  • World’s Driest Hot Desert Set To See Major Desert Bloom Next Month, The First Since 2022
  • New 3D Reconstructions Show Massive Sauropods Could Move Their Tails Like Your Pet Doggo
  • POV: You Strapped A Camera To A Seabird’s Butt And Discovered They Prefer To Poop While Flying
  • Enceladus Creates An Unlikely Rainbow Across One of Saturn’s Rings, Puzzling Astronomers
  • Should We All Be Journaling? Here’s What Psychologists Say
  • Mercury Is Shrinking – And Its Surface May Have Just Revealed By How Much
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version